A computational study on the inhibition of MCL-1 anti-apoptotic protein to activate apoptosis in cancer cells via commercially available natural product derivatives
dc.contributor.author | Costa,M.S.V | |
dc.contributor.author | Ratnaweera,C.N | |
dc.contributor.author | Udawatte,C.S | |
dc.date.accessioned | 2025-02-25T03:16:49Z | |
dc.date.available | 2025-02-25T03:16:49Z | |
dc.date.issued | 2019-05 | |
dc.description | Technical Sessions : A - 32 Page 39 | |
dc.description.abstract | Bcl-2, BCL-XL and MCL-1 (Myeloid cell leukemia-1) are important anti-apoptotic proteins. The objective of this research was to identify commercially available natural product derivatives to inhibit MCL-1. Ligands were obtained from the ZINC12 database which provides 30793 chemically modified, commercially available natural product derivatives. | |
dc.identifier.uri | https://dr.ichemc.ac.lk/handle/123456789/326 | |
dc.language.iso | en | |
dc.publisher | Institute of Chemistry Ceylon | |
dc.relation.ispartofseries | 36; 2 | |
dc.subject | natural product | |
dc.subject | anti-apoptotic protein | |
dc.subject | Crystal structures | |
dc.title | A computational study on the inhibition of MCL-1 anti-apoptotic protein to activate apoptosis in cancer cells via commercially available natural product derivatives | |
dc.type | Article |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- A computational study on the inhibition of MCL-1 anti-apoptotic protein to activate apoptosis in cancer cells via commercially available natural product derivatives.pdf
- Size:
- 83.36 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: